Advertisement

Topics

Millennium Research Group (MRG) Company Profile

19:26 EDT 21st July 2018 | BioPortfolio

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer loyalty tracking, facility-level procedure forecasting, and customized solutions.


News Articles [756 Associated News Articles listed on BioPortfolio]

Andrew Lukowiak Departs AltheaDx to Become Millennium Health’s CEO

Andrew Lukowiak has been appointed CEO of Millennium Health. Lukowiak comes to San Diego-based Millennium from precision medicine company AltheaDx, also based in San Diego, where he was chief operatin...

QIAGEN-Aktie: Leerverkäufer Millennium International Management hat sich etwas zurückgezogen

KJ Venlo - Leerverkäufer Millennium International Management LP hat Netto-Leerverkaufsposition in Aktien der QIAGEN N.V. leicht abgebaut: Die Hedgefonds-Manager von Millennium International Managem.....

QIAGEN-Aktie: Leerverkäufer Millennium International Management tritt den Rückzug an!

KJ Venlo - Leerverkäufer Millennium International Management LP kürzt Netto-Leerverkaufsposition in Aktien der QIAGEN N.V.: Die Hedgefonds-Manager von Millennium International Management LP treten ....

Millennium:Looking for First in Class and Best in Class Opportunities in Oncology and Hematology

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Dan Curran, Vice President, Corporate Development at Millennium

Kern Medical to Implement Cerner Millennium EHR & PHM Platform

Kern Medical, a 222-bed acute care teaching center based in Bakersfield, California, has selected Cerner to implement the Cerner Millennium EHR and Cerner HealtheIntent big data and insights platfor...

Millennium Management LLC Reduces Position in Cardinal Health Inc

Millennium Management LLC lowered its holdings in Cardinal Health Inc by 29.0% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 181,981 sha...

Trinity Biotech (TRIB) Shares Bought by Millennium Management LLC

Millennium Management LLC boosted its position in Trinity Biotech by 20.8% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission . The firm owned 4...

Millennium Leverages Lightbeam to Drive Value-Based Efforts for 7 ACOs and 6 Medicare Advantage Plans

More than 300 providers supporting 170,000 patients will leverage Lightbeam’s solutions to enhance patient care, lower costs, and manage multiple payer contracts Expa...

PubMed Articles [3168 Associated PubMed Articles listed on BioPortfolio]

Does Timing of Surgery Affect Treatment of the Terrible Triad of the Elbow?

BACKGROUND This study investigated the influence of surgical timing on the treatment of terrible triad of the elbow (TTE). MATERIAL AND METHODS After exclusion, 63 patients were enrolled in this study...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Group I introns are widespread in archaea.

Group I catalytic introns have been found in bacterial, viral, organellar, and some eukaryotic genomes, but not in archaea. All known archaeal introns are bulge-helix-bulge (BHB) introns, with the exc...

The Sustainable Development Goal for Urban Sanitation: Africa's Statistical Tragedy Continues?

Sanitation delivery in the urban areas of sub-Saharan African countries has been a chronic issue, particularly difficult to tackle. Under the Millennium Development Goals, the sanitation target in urb...

Experimental animal study of docetaxel combined with carboplatin in the treatment of retinoblastoma.

The synergistic effects of docetaxel (DTX) combined with carboplatin in the treatment of retinoblastoma (RB) was explored in mouse RB xenografts compared with carboplatin alone and DTX alone groups. R...

Clinical Trials [5713 Associated Clinical Trials listed on BioPortfolio]

The Millennium Villages Project: Assessing the Impact on Child Survival and the Millennium Development Goals in Sub-Saharan Africa

The Millennium Villages Project involves the coordinated and simultaneous delivery of a package of proven interventions in health, agriculture, infrastructure and education. The project wo...

MLN 9708 in Induction and Consolidation for Adults With AML >= 60 Years of Age

This research study is evaluating drugs called Millennium 9708 (referred to as MLN9708) in combination with standard therapy for acute myeloid leukemia (AML) consisting of daunorubicin and...

Safety and Efficacy Study of Single Weekly Bortezomib in Newly Diagnosed Multiple Myeloma

This is a research study to see if a new drug called bortezomib is useful to treat multiple myeloma in people who are newly diagnosed, and have not yet received treatment for their disease...

Treating Sleep Problems in VA Adult Day Health Care

The Veterans Millennium Health Care and Benefits Act (Millennium Act) of 1999 mandated the Department of Veterans Affairs (VA) to provide non-institutional long-term care to veterans. Adul...

Research Participants' Perceptions of Their Experience in Clinical Studies

This study will examine how research volunteers experience their participation in studies in order to develop surveys to be used by research centers trying to improve the experience of the...

Companies [3029 Associated Companies listed on BioPortfolio]

Millennium Research Group (MRG)

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and ...

Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider o...

Millennium Dental Technologies, Inc.

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a first-in-class proteasome inhibitor, and has a robust cl...

Millennium: The Takeda Oncology Company

Millennium: The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets a first-in-class proteasome inhibitor, and has a robust clinical de...

Millennium Pharmaceuticals, Inc.

Millennium Pharmaceuticals, The Takeda Oncology Company, a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE, a novel cancer product, and has a robust clinical developme...

More Information about "Millennium Research Group (MRG)" on BioPortfolio

We have published hundreds of Millennium Research Group (MRG) news stories on BioPortfolio along with dozens of Millennium Research Group (MRG) Clinical Trials and PubMed Articles about Millennium Research Group (MRG) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Millennium Research Group (MRG) Companies in our database. You can also find out about relevant Millennium Research Group (MRG) Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record